Predictive Profiling of SARS-CoV-2 Variants by Deep Mutational Learning
Predictive Profiling of SARS-CoV-2 Variants by Deep Mutational Learning
Webinar
Variant Libraries
In Silico Accelerated Antibody Characterization
MabSilico Astrid Musnier
Webinar
Variant Libraries
Accelerated Antibody Discovery Targeting the SARS-CoV-2 Spike Protein for COVID-19 Therapeutic Potential
Rapid deployment of technologies capable of high-throughput and high-resolution screening is imperative for timely response to viral outbreaks. Risk mitigation in the form of leveraging multiple advanced technologies further increases the likelihood of identifying efficacious treatments in aggressive timelines.